Role of the gut microbiota in MASLD-associated hepatocellular carcinoma: mechanistic insights and therapeutic targets

Metabolic dysfunction-associated steatotic liver disease (MASLD) is rapidly replacing viral hepatitis as a leading cause of hepatocellular carcinoma (HCC) worldwide. MASLD-related HCC (MASLD-HCC) displays a distinctive and complex biological phenotype, particularly in terms of its immune microenvironment and response to immunotherapy, however, the related underlying mechanisms remain insufficiently investigated. Recent studies have suggested a crucial role of the gut microbiota in regulating hepatic inflammatory and immune responses during the malignant transformation from MASLD to HCC, known as the gut-liver axis. In this review, the dynamic alterations in the gut microbiome during MASLD-HCC initiation and development are summarized. The relevant mechanisms, including the gut–liver axis, hepatic immune reprogramming and microbial metabolite-induced signalling pathways, are discussed in this review. Moreover, several potential microbiota-targeted strategies for preventing or treating MASLD-HCC, including dietary intervention, probiotics, antibiotics, fecal microbiota transplantation, natural products and plant-derived bioactive compounds, are evaluated. Finally, challenges and future directions for basic and translational research in this field are discussed. Taken together, these findings suggest that the gut microbiota is a novel diagnostic biomarker and therapeutic target for MASLD-HCC management.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-16
DOI
https://doi.org/10.3389/fimmu.2026.1939930
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Role of the gut microbiota in MASLD-associated hepatocellular carcinoma: mechanistic insights and therapeutic targets

陈高羽, Mingyang Tao, Jiayu Chang, Yajuan Chu et al.
4 links
Frontiers in Immunology
Gut microbiota and health
article

Role of the gut microbiota in MASLD-associated hepatocellular carcinoma: mechanistic insights and therapeutic targets

陈高羽, Mingyang Tao, Jiayu Chang, Yajuan Chu, Junfeng Yin, Yefei Zhu, Jianing Zhu, Xin Chen, Xuebing Yan, Yufang Chen, Ying Wang
article en

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is rapidly replacing viral hepatitis as a leading cause of hepatocellular carcinoma (HCC) worldwide. MASLD-related HCC (MASLD-HCC) displays a distinctive and complex biological phenotype, particularly in terms of its immune microenvironment and response to immunotherapy, however, the related underlying mechanisms remain insufficiently investigated. Recent studies have suggested a crucial role of the gut microbiota in regulating hepatic inflammatory and immune responses during the malignant transformation from MASLD to HCC, known as the gut-liver axis. In this review, the dynamic alterations in the gut microbiome during MASLD-HCC initiation and development are summarized. The relevant mechanisms, including the gut–liver axis, hepatic immune reprogramming and microbial metabolite-induced signalling pathways, are discussed in this review. Moreover, several potential microbiota-targeted strategies for preventing or treating MASLD-HCC, including dietary intervention, probiotics, antibiotics, fecal microbiota transplantation, natural products and plant-derived bioactive compounds, are evaluated. Finally, challenges and future directions for basic and translational research in this field are discussed. Taken together, these findings suggest that the gut microbiota is a novel diagnostic biomarker and therapeutic target for MASLD-HCC management.

Frontiers in ImmunologyVol. 17
Fudan University (CN), Fudan University Shanghai Cancer Center (CN), Zhongshan Hospital (CN), Northern Jiangsu People's Hospital (CN), Yangzhou University (CN)
Jiangsu Commission of Health, National Natural Science Foundation of China, China Postdoctoral Science Foundation, Natural Science Foundation of Jiangsu Province, YangZhou Science and Technology Bureau
Good health and well-being
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon